By Elizabeth Earin
A pathology workflow platform doesn’t just support operations — it provides the foundation for them.
The architecture behind today’s decision will influence tomorrow’s turnaround times, staffing flexibility, subspecialty collaboration, and ability to scale. Yet most laboratories must make that decision before they can fully see how their needs will evolve.
Volume shifts. Teams redistribute. AI enters the workflow. What feels sufficient during evaluation can become restrictive once digital pathology carries real clinical responsibility.
That’s why labs evaluating top cloud-based pathology workflow solutions often find themselves looking more broadly at leading providers of specialist workflows in healthcare. The goal isn’t to pick the most advanced solution, but to choose a platform that is robust now and can adapt as real-world conditions evolve.
This article is designed to help labs think through that decision more clearly, regardless of size or structure.
Pathology Workflows Place Unique Demands on Platforms
Pathology leaders already understand that their workflows don’t behave like most clinical systems. Work is case-based, complexity varies widely, subspecialty expertise is limited, and turnaround time directly affects downstream care. Coordination across people, systems, and sites is a constant, not an exception.
Where this becomes relevant to platform decisions is in how those realities are handled under pressure.
Many pathology platforms inherit architectural ideas from imaging, particularly PACS, but the way that architecture is adapted matters. Platforms that treat pathology as a simple extension of image viewing often perform well early, then struggle as volume, variability, and coordination demands increase.
Platforms that remain stable as workflows tend to share one characteristic: they are designed with direct knowledge of how pathology actually operates. Not in theory, and not by retrofitting another specialty’s application, but with a clear understanding of case variability, sign-out patterns, subspecialty collaboration, and laboratory constraints.
That difference is rarely obvious in early demonstrations, but it becomes increasingly visible over time.
The Real Risk Isn’t Going Digital — It’s Getting Stuck
For most labs, the question isn’t whether digital pathology has value. That case has largely been made. The harder part begins after the decision to move forward – when digital workflows stop being evaluated and start carrying real clinical responsibility.
That transition is where problems tend to appear.
As digital pathology moves into routine use, labs often find themselves working through practical issues that weren’t obvious early on:
- fitting digital tools into workflows that already work reasonably well
- maintaining turnaround times as volume and case mix increase
- expanding LIS, scanners, and other systems without adding steps
- putting appropriate oversight in place without slowing sign-out
- integrating AI algorithms that aid in diagnosis
None of these challenges are theoretical. They surface during real cases, under real time pressure. How a workflow platform handles this shift – from evaluation to daily clinical use – often determines whether digital pathology becomes an asset or an ongoing source of frustration.
Five Practical Questions Labs Should Ask Before Choosing a Platform
This is where platform evaluations usually succeed or quietly fall apart. These questions help surface issues that don’t show up in demos but matter over time.
1. What changes when our volume or staffing model shifts?
Why this matters:
Volume, coverage, and subspecialty demand rarely stay fixed. If a platform only works under today’s conditions, it becomes fragile as soon as reality changes.
What a good answer sounds like:
Clear explanations of how the platform handles fluctuating workloads, shared or rotating pathologists, and added outreach or service lines, without relying on manual coordination.
How this affects your decision:
If growth introduces workarounds, those workarounds usually become permanent. Platforms that absorb change cleanly are far easier to live with long term.
2. How flexible are workflows once the system is live?
Why this matters:
Many platforms are easy to configure early and hard to adjust later, especially once clinical use begins.
What a good answer sounds like:
Specific examples of what can be changed internally, what requires reconfiguration, and what requires outside support, without vague assurances.
How this affects your decision:
Long-term flexibility often matters more than initial setup. Platforms that resist change tend to slow operations over time.
3. How does integration work day-to-day?
Why this matters:
Integration isn’t just about connecting systems; it’s about how those systems behave together under real clinical conditions.
What a good answer sounds like:
Practical explanations of how the platform handles exceptions, system updates, version changes, and audit needs in mixed environments.
How this affects your decision:
If integration only works under ideal conditions, complexity becomes evident later as delays, inconsistencies, or added oversight burden.
4. What does “cloud-based” actually enable for us?
Why this matters:
Cloud only matters if it changes how work gets done, not if it’s just a hosting detail.
What a good answer sounds like:
Clear links between cloud deployment and operational outcomes like remote sign-out, distributed collaboration, and predictable performance under load.
How this affects your decision:
If cloud doesn’t materially improve flexibility or resilience, its long-term value may be limited.
5. What assumptions does the platform make about how pathology work happens?
Why this matters:
This question often reveals limitations that aren’t obvious at first.
What a good answer sounds like:
An acknowledgment that workflows vary, organizations evolve, teams may be distributed, and staffing models change over time – without forcing rigid, uniform processes.
How this affects your decision:
Platforms designed around real pathology practice tend to adapt over time. Those built on overly simple assumptions usually require compromises later.
Final Thought
Pathology has always demanded more from workflow platforms than most clinical domains. As staffing pressures persist, case complexity increases, and collaboration becomes more distributed, and that reality now applies to laboratories of every size.
The most durable platform decisions are the ones made with that complexity in mind: choosing solutions designed not just for today’s workflow, but for the realities that will define tomorrow’s practice.
